Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C

• Taylor Aiken,

  Affiliation Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Ari Garber,

  Affiliation Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Dawn Thomas,

  Affiliation Allogen Laboratories, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Nicole Hamon,

  Affiliation Allogen Laboratories, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Rocio Lopez,

  Affiliation Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Rajesh Konjeti,

  Affiliation Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America

  ⨯
• Arthur McCullough,

  Affiliation Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Nizar Zein,

  Affiliation Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• John Fung,

  Affiliation Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Medhat Askar,

  Affiliation Transplant Immunology, Baylor University Medical Center, Dallas, Texas, United States of America

  ⨯
• Binu V. John

  * E-mail: binu.john@vcuhealth.org

  Affiliations Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America, Gastroenterology and Hepatology, Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States of America

  ⨯